The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...
The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...
Shares of Danish weight-loss drug maker Novo Nordisk rose 1.3% on Tuesday as US President Joe Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid. “This is an ...
picture alliance / Contributor / Getty Images Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies' weight-loss drugs in ...
In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other profitable European stocks. After the U.S. Presidential elections, the global economies ...
The approval of exenatide 1.2 ml and 2.4 ml prefilled pen injection, referencing Byetta, reflects the company’s deep innovation and regulatory capabilities in complex pharmaceuticals and its ...
Novo Nordisk’s (NVO) (OTCPK:NONOF) contract with Swiss medical device maker Ypsomed (OTCPK:YPHDF) includes a deal to supply injection pens for Danish drugmaker’s next-gen obesity therapy ...
LONDON (Reuters) – Swiss medical technology company Ypsomed’s contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker’s next-generation experimental obesity drug ...
Against a backdrop of manufacturing prioritisation, Novo Nordisk’s contract with Swiss medical technology company Ypsomed could include the supply of injection pens for CagriSema, the former’s ...
Against a backdrop of manufacturing prioritisation, Novo Nordisk’s contract with Swiss medical technology company Ypsomed could include the supply of injection pens for CagriSema ... an automated ...
Novo Nordisk, the maker of weight-loss drugs Ozempic and Wegovy, is suing at least five Chicago-area medical spas and health clinics, alleging they each are using false advertising and deceptive ...